Radiotherapy and Anti-PD-1 in Low-risk ES-ENKTCL

Clinical trial NCT05149170 · UNKNOWN

Trial details

NCT number: NCT05149170
Sponsor: Chinese Academy of Medical Sciences
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Early-stage Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type

Start date: 2021-10-01
Primary completion: 2022-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.